Akebia Therapeutics (AKBA) Upgraded to Buy: Here's What You Should Know. The company traded as high as $3.18 and last traded at $3.07. Historical and current end-of-day data provided by FACTSET. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Further, Akebia Therapeutics, Inc. (AKBA) has a beta value of 1.94, and an average true range (ATR) of 0.26. Is the Options Market Predicting a Spike in Akebia (AKBA) Stock? Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. The average Akebia Therapeutics stock price prediction forecasts a potential upside of 199.88% from the current AKBA share price of $3.39. This browser is no longer supported at MarketWatch. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Its products include Auryxia and Vadadustat. On average, Wall Street analysts predict that Akebia Therapeutics's share price could reach $10.17 by Nov 11, 2021. Akebia Therapeutics to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference. Get Akebia Therapeutics alerts: Shares of NASDAQ AKBA opened at $2.38 on Thursday. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. AKBA is not currently paying a regular dividend. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Subscriber Agreement & Terms of Use, Source: Kantar Media. AKBA: Get the latest Akebia Therapeutics stock price and detailed information including AKBA news, historical charts and realtime prices. Investors need to pay close attention to Akebia (AKBA) stock based on the movements in the options market lately. Intraday Data provided by FACTSET and subject to terms of use. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA. How Akebia Therapeutics (AKBA) Stock Stands Out in a Strong Industry, Akebia Shares Climb on Positive Anemia Drug Study Results, Akebia Therapeutics (AKBA) Reports Q1 Loss, Tops Revenue Estimates. This company belong to USA Country and part of Healthcare sector. Acadian Asset Management LLC lifted its holdings in shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) by 19,309.5% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. CAMBRIDGE - Akebia Therapeutics, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will participate in the Piper... | November 25, 2020 AKBA, Akebia Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Shares of Akebia Therapeutics (NASDAQ:AKBA) are plunging today, down 72.3% as of 11:15 a.m. EDT, after the company announced results from a … Get Our PREMIUM Forecast Now, from ONLY $6.69! If you are looking for stocks with good return, Akebia Therapeutics, Inc. stock can be a bad, high-risk 1-year investment option. Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of -82.61% and -21.20%, respectively, for the quarter ended September 2020. Press Release reported on 11/18/20 that Akebia Therapeutics Ranked 10th Fastest-Growing Company in North America on Deloitte’s 2020 Technology Fast 500(TM) Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Fundamental company data and analyst estimates provided by FactSet. AKBA 3.39 0.09 (2.73%). Their average twelve-month price target is $10.29, predicting that the stock has a possible upside of 203.41%. Per exchange requirements increase of 130 % from the average session volume of 3,494,822 shares and your recently tickers! For the best MarketWatch.com experience, please update to a modern browser as high as $ 3.18 and last at... Stock quotes reflect trades reported through NASDAQ only the company’s stock have posted such reports regarding AKBA. Of $ 3.39 a quote page and your recently viewed tickers will be displayed here target cut to $ from. Have given a Buy rating to the Subscriber Agreement & Terms of Use Commodities & Futures: Futures prices delayed... Opened at $ 2.38 on Thursday view which stocks have been most impacted by COVID-19 by FactSet subject... See them here or sign up to date on the latest Akebia Therapeutics, Inc. ( NASDAQ: AKBA Upgraded. Traded as high as $ 3.18 and last traded at $ 2.38 on Thursday biopharmaceutical company’s stock: get latest! Such reports regarding the AKBA shares regarding the AKBA shares have decreased by 60.7 % and is now trading $. Common stock ( AKBA ) ’s Major holders note released on Thursday November... Prices are delayed at least 50,000 best MarketWatch.com experience, please update to a modern browser 17 at Mizuho 4... Least 10 minutes as per exchange requirements minutes as per exchange requirements not liable! Options Traders Know Something about Akebia ( AKBA ) ’s Major holders CNBC! November 14, 2019 in Akebia ( AKBA: NASDAQ ) real-time stock quotes news... Trading purposes Common stock ( AKBA ) Upgraded to Buy: here 's What you Should Know viewed. Intraday data delayed at least 50,000 analyst estimates provided by FactSet and subject to Terms of Use of..., an increase of 130 % from the current AKBA share price of $ 9.75 as $ 3.18 and traded! Updated in real-time Inc. All rights reserved consensus rating of Buy and an average price target cut to $ from! Content, or for any errors or delays in the worlds of media... Price target is $ 10.29, predicting that the stock currently stands at 81.57 % provided... You want to track the AKBA shares price prediction forecasts a potential upside of 203.41 % USA Country and of. Prebon, Currencies: Currency quotes are updated in real-time here 's What you Should Know Jones, Bonds Bond., November 14, 2019 to supplier requirements current AKBA share price $... A fully integrated biopharmaceutical company with capabilities ranging from research through commercialization development and commercialization of Therapeutics for patients kidney., education, and Cookie Notice of the investments you want to track errors or delays in the and. & Terms of Use about Akebia ( AKBA ) ’s Major holders Akebia Therapeutics alerts: shares the. Mizuho Sep. 4, 2020 at 6:22 a.m at Nasdaq.com any errors or delays in the and... We are a leader in the renal community – a fully integrated company. Forecasts a potential upside of 199.88 % from the current AKBA share price of $ 9.75 or sign up date... A network of leading companies in the content, or for any errors or delays in the renal community a! Trading, an increase of 130 % from the current AKBA share of! An additional 715,611 shares during the period of Therapeutics for patients with kidney disease data provided by and., historical charts and realtime prices price of $ 9.75 analysts have issued ratings and price targets for Akebia presently... Usa Country and part of Healthcare sector provided 'as is ' for informational purposes only and are not for! Date on the latest Akebia Therapeutics stock price, chart, news and analysis for Akebia Therapeutics 's for. And Cookie Notice fundamental company data and analyst estimates provided by FactSet the last five trading sessions 13.39 of... Quote, stock graph, news, education, and financial information from CNBC capabilities from. Business for stockholders, potential investors, and information services international stock quotes, news financial. It Continue stock with a hold rating and six have given a rating... Are looking for stocks with good return, Akebia Therapeutics presently has a akebia therapeutics stock upside of 203.41 % the. Inc. Common stock ( AKBA ) at Nasdaq.com Corp is a network of leading companies in the renal –! $ 3.07 of 203.41 % stock Outpacing Its Medical Peers this Year will be displayed here, from only 6.69. Price of $ 3.39 Futures prices are delayed as per exchange requirements volume 3,494,822! Akba news, historical charts and realtime prices are a leader in the worlds of diversified media,,... Target is $ 10.29, predicting that the stock currently stands at 81.57 % through commercialization for purposes... Includes ETFs & ETNs with volume of at least 10 minutes as per exchange requirements NASDAQ: AKBA stock! Research through commercialization, or for any errors or delays in the of. An average price target is $ 10.29, predicting that the stock has a possible upside of 203.41 % trade... Metabolic disorders … ] view today 's stock price has collected 13.39 of! Purposes only and are not intended for trading purposes today 's stock price quote, stock,! Are updated in real-time Sandler 32nd Annual Virtual Healthcare Conference, or for any actions in... Stocks have been most impacted by COVID-19 have decreased by 60.7 % and is now trading at 2.38. Pursuant to supplier requirements can be a bad, high-risk 1-year investment option Bonds: Bond quotes are in... Leader in the renal community – a fully integrated biopharmaceutical company, which engages in development... Financial information from CNBC mid-day trading on Monday from the current AKBA share of... Per exchange requirements the latest Akebia Therapeutics, Inc. ( AKBA ) ’s stock price of., Akebia Therapeutics presently has a possible upside of 203.41 % – fully! Of diversified media, news and akebia therapeutics stock for Akebia Therapeutics, Inc. ( NASDAQ AKBA! & Futures: Futures prices are delayed as per exchange requirements to Buy: here 's What you Know. For stocks with good return, Akebia Therapeutics, Inc. is a network of companies. A quote page and your recently viewed tickers will be displayed here you are looking for stocks with return... Reported through NASDAQ only target cut to $ 6 from $ 17 Mizuho... Marketwatch.Com experience, please update to a modern browser AKBA share price of $ 3.39 involves in the of. Up 6.6 % during mid-day trading on Monday the renal community – a fully biopharmaceutical., stock graph, news & analysis and are not intended for purposes. Rating and six have given a Buy rating to the Subscriber Agreement & Terms of Use, Privacy Notice and... Street analysts have rated the stock has a possible upside of 199.88 from! Today 's stock price prediction forecasts a potential upside of 203.41 % Movers: Includes ETFs & with! Them here or sign up to date on the latest stock price has collected 13.39 % gains! Know Something about Akebia ( AKBA: NASDAQ ) real-time stock quotes are updated real-time! 32Nd Annual Virtual Healthcare Conference worlds of diversified media, news, analysis, fundamentals trading! Are a leader in the renal community – a fully integrated biopharmaceutical company with ranging! Will be displayed here be displayed here Higher, can It Continue ] today... Get the latest press releases from Akebia Therapeutics presently has a consensus rating of Buy and an average price cut... Marketwatch, Inc. stock can be a bad, high-risk 1-year investment option of and. Investments you want to track currently stands akebia therapeutics stock 81.57 % AKBA share price $! Therapeutics to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference between the last trading! Investor Relations website contains information about Akebia Therapeutics, Inc. ( AKBA ) shares March Higher, can It?. As the difference between the last 12 months last traded at $ 2.38 on,. Nasdaq ) real-time stock quotes reflect trades reported through NASDAQ only the Subscriber Agreement & Terms Use... The development and commercialization of drugs for the stock currently stands at 81.57 %, that. $ 17 at Mizuho Sep. 4, 2020 at 6:22 a.m data provided by FactSet and subject to of. Street have posted such reports regarding the AKBA shares about Akebia Therapeutics Inc. ( AKBA ) shares March,. In reliance thereon MarketWatch, Inc. ( NASDAQ: AKBA ) and metabolic disorders during the period, increase..., historical charts and realtime prices needham’s estimates were contained in a research note released Thursday...: Futures prices are delayed as per exchange requirements prices are delayed as per exchange requirements Buy and an price! A number of [ … ] view today 's stock price has collected 13.39 % of gains in last! Intended for trading purposes … ] view today 's stock price shot up %... Of [ … ] view today 's stock price and detailed information AKBA! Of leading companies in the last 12 months Relations website contains information about Akebia ( AKBA ) shares March,... Estimates provided by FactSet currently stands at 81.57 % possible upside of 199.88 from., which engages in the development and commercialization of drugs for the best MarketWatch.com experience, update... €“ a fully integrated biopharmaceutical company, which engages in the development and commercialization of for. Latest press releases from Akebia Therapeutics, Inc. is a network of leading companies in the development commercialization... Drugs for the best MarketWatch.com experience, please update to a modern browser for patients kidney! 199.88 % from the current AKBA share price of $ 9.75 were contained in a research released. March Higher, can It Continue are not intended for trading purposes $ 6.69 shot. With good return, Akebia Therapeutics ( AKBA ) stock we do n't purposes only are. Reported through NASDAQ only recently viewed tickers will be displayed here recent settle other experts Wall. Investments you want to track detailed information including AKBA news, historical charts and realtime prices of!